Titan Pharmaceuticals (TTNP) Competitors $5.92 +1.14 (+23.70%) Closing price 10/1/2025Extended Trading$5.92 0.00 (0.00%) As of 10/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TTNP vs. IOBT, QTTB, PMN, SNYR, FBLG, MTVA, NNVC, RLYB, ALLR, and LSTAShould you be buying Titan Pharmaceuticals stock or one of its competitors? The main competitors of Titan Pharmaceuticals include IO Biotech (IOBT), Q32 Bio (QTTB), Promis Neurosciences (PMN), Synergy CHC (SNYR), FibroBiologics (FBLG), MetaVia (MTVA), NanoViricides (NNVC), Rallybio (RLYB), Allarity Therapeutics (ALLR), and Lisata Therapeutics (LSTA). These companies are all part of the "pharmaceutical products" industry. Titan Pharmaceuticals vs. Its Competitors IO Biotech Q32 Bio Promis Neurosciences Synergy CHC FibroBiologics MetaVia NanoViricides Rallybio Allarity Therapeutics Lisata Therapeutics Titan Pharmaceuticals (NASDAQ:TTNP) and IO Biotech (NASDAQ:IOBT) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability. Which has higher earnings and valuation, TTNP or IOBT? Titan Pharmaceuticals is trading at a lower price-to-earnings ratio than IO Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTitan PharmaceuticalsN/AN/A-$4.71M-$2.95-2.01IO BiotechN/AN/A-$95.49M-$1.58-0.33 Is TTNP or IOBT more profitable? Titan Pharmaceuticals' return on equity of -108.60% beat IO Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Titan PharmaceuticalsN/A -108.60% -95.64% IO Biotech N/A -281.82%-169.29% Which has more risk and volatility, TTNP or IOBT? Titan Pharmaceuticals has a beta of 1.37, meaning that its share price is 37% more volatile than the S&P 500. Comparatively, IO Biotech has a beta of 0.21, meaning that its share price is 79% less volatile than the S&P 500. Does the media favor TTNP or IOBT? In the previous week, IO Biotech had 9 more articles in the media than Titan Pharmaceuticals. MarketBeat recorded 11 mentions for IO Biotech and 2 mentions for Titan Pharmaceuticals. Titan Pharmaceuticals' average media sentiment score of 1.36 beat IO Biotech's score of -0.43 indicating that Titan Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Titan Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive IO Biotech 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer TTNP or IOBT? IO Biotech has a consensus target price of $8.00, suggesting a potential upside of 1,454.61%. Given IO Biotech's stronger consensus rating and higher probable upside, analysts plainly believe IO Biotech is more favorable than Titan Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Titan Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00IO Biotech 1 Sell rating(s) 4 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.17 Do institutionals and insiders believe in TTNP or IOBT? 31.5% of Titan Pharmaceuticals shares are held by institutional investors. Comparatively, 54.8% of IO Biotech shares are held by institutional investors. 0.7% of Titan Pharmaceuticals shares are held by insiders. Comparatively, 2.3% of IO Biotech shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryIO Biotech beats Titan Pharmaceuticals on 8 of the 13 factors compared between the two stocks. Get Titan Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TTNP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TTNP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TTNP vs. The Competition Export to ExcelMetricTitan PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$7.88M$3.32B$6.11B$10.53BDividend YieldN/A2.29%5.51%4.67%P/E Ratio-2.0121.6185.6926.92Price / SalesN/A424.41583.01184.15Price / CashN/A46.3226.3031.10Price / Book2.2210.0613.246.71Net Income-$4.71M-$52.22M$3.30B$276.35M7 Day Performance23.70%5.87%4.64%3.10%1 Month Performance40.07%12.07%8.36%10.19%1 Year Performance15.50%26.14%87.97%40.37% Titan Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TTNPTitan Pharmaceuticals0.9482 of 5 stars$5.93+23.7%N/A+11.8%$7.88MN/A-2.0110News CoveragePositive NewsShort Interest ↓High Trading VolumeIOBTIO Biotech3.3911 of 5 stars$0.36-0.8%$8.00+2,109.9%-58.1%$23.85MN/A-0.2330Gap UpHigh Trading VolumeQTTBQ32 Bio2.9242 of 5 stars$1.94+0.2%$12.17+525.9%-95.2%$23.72M$1.16M-0.4539PMNPromis Neurosciences2.5832 of 5 stars$0.43-1.4%$4.33+898.5%-49.7%$23.35MN/A-2.075News CoverageGap UpSNYRSynergy CHC3.8956 of 5 stars$2.45+1.7%$10.00+308.2%-40.2%$23.13M$34.83M6.4540FBLGFibroBiologics2.2084 of 5 stars$0.55-9.8%$12.67+2,194.7%-80.6%$23.08MN/A-1.5310Gap UpHigh Trading VolumeMTVAMetaVia2.3819 of 5 stars$0.94flat$7.50+696.5%N/A$22.79MN/A0.008Positive NewsNNVCNanoViricides0.2876 of 5 stars$1.42-0.4%N/A-1.4%$22.74MN/A-1.9720RLYBRallybio3.3064 of 5 stars$0.54-3.1%$5.00+825.9%-48.3%$22.56M$761K-0.5740Analyst UpgradeShort Interest ↓ALLRAllarity Therapeutics2.6938 of 5 stars$1.54-3.5%$9.25+502.6%-6.3%$22.44MN/A0.0010LSTALisata Therapeutics2.3619 of 5 stars$2.54+0.2%$23.50+827.0%-16.4%$22.20M$1.07M-1.1430Gap Down Related Companies and Tools Related Companies IO Biotech Alternatives Q32 Bio Alternatives Promis Neurosciences Alternatives Synergy CHC Alternatives FibroBiologics Alternatives MetaVia Alternatives NanoViricides Alternatives Rallybio Alternatives Allarity Therapeutics Alternatives Lisata Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TTNP) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Titan Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Titan Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
